PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'UMRS 1269 INSERM/Sorbonne University, Nutriomics, Faculté de médecine Pitié-Salpêtrière, F-75013, Paris, France; Member of the scientific council of the Groupe d\'Etude et de Recherche en Lipidomique (GERLI), France.\', \'Université Côte d\'Azur, CNRS, Inserm, iBV, Nice, France; Member of the scientific council of the Groupe d\'Etude et de Recherche en Lipidomique (GERLI), France.\', \'Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, F-67000, Strasbourg, France; Member of the scientific council of the Groupe d\'Etude et de Recherche en Lipidomique (GERLI), France. Electronic address: vitalen@unistra.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0300-9084(20)30155-310.1016/j.biochi.2020.07.001
?:hasPublicationType
?:journal
  • Biochimie
is ?:pmid of
?:pmid
?:pmid
  • 32649962
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.554
?:rankingScore_hIndex
  • 116
is ?:relation_isRelatedTo_publication of
?:title
  • High prevalence for obesity in severe COVID-19: Possible links and perspectives towards patient stratification.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all